NDC 16714-889-01 - ERTAPENEM SODIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16714-889
- Requested NDC
- 16714-889-01
- Package NDCs from labels
- 16714-889-01, 16714-889-10
- Manufacturer
- NorthStar RxLLC | Gland Pharma Limited
- Effective date
- 2025-12-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ERTAPENEM SODIUM - NorthStar RxLLC | Gland Pharma Limited | NorthStar RxLLC | Gland Pharma Limited | 2025-12-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16714-889-01 | ERTAPENEM SODIUM | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 5 | |
| 16714-889-10 | ERTAPENEM SODIUM | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16714-889-01 | EA - Each | 16714-889 | adcf31ab-b851-4b6b-8f6f-0b238dd3eeb7 | 1 | 2021-10-08 |
| 16714-889-10 | EA - Each | 16714-889 | 16bccce1-41b8-40c0-8513-0198f16169ac | 1 | 2021-10-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate | SODIUM BICARBONATE | International Medication Systems, Limited | 77698221-a01d-4568-a7bc-d3d4e982875d | 2021-12-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| 8.4% SODIUM BICARBONATE | 8.4% SODIUM BICARBONATE | HF Acquisition Co. LLC, DBA HealthFirst | 74d8bb7a-9e7a-105f-e053-2a91aa0aec92 | 2021-05-03 | Warnings, Adverse reactions | 8MDF5V39QO |
| ERTAPENEM SODIUM | ERTAPENEM | Dr.Reddys Laboratories Inc., | 32d9f095-ca39-7e22-6264-b54f2daaee57 | 2021-04-30 | Warnings, Adverse reactions | ANDA212040 1734683 2T90KE67L0 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | bfc9c321-665c-ca97-e053-2995a90a7954 | 2021-04-12 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | 15605a6d-6c90-47d5-9d1f-f66a3f27d5fc | 2017-12-13 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | e0b2f0d3-3849-4bdf-b3d4-e14e520e36ce | 2017-11-01 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | fa10d93d-b3ed-4675-a117-f573d9e72bca | 2017-10-30 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | e9698a4f-1a95-4f28-a945-e8009d1d6dd4 | 2017-09-27 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.